We offer products that are optimized for your needs.
We value trust and communicate with customers.
Custom synthesis of peptides of any purity, length or complexity (modifications included). >95% success rate with money back guarantee.
Depending on the complexity of the project, we employ both an automated and manual methodology for our peptide synthesis process. We typically carry out our purification by preparative RP-HPLC and analysis by ESI-MS ionization.
A peptide library is a combination of systematically arranged peptides used in screening for identification of critical bioactive peptides. These libraries have a variety of applications in areas such as drug discovery, proteomics, immunotherapy, epitope identification and many more.
The increasing popularity of peptides due to their diverse cosmetic properties has led to a rise in demand for peptides as key ingredients in the cosmetic industry.
Bio Basic has the capability to synthesize peptides related to the cosmetic industry (note: research related; not for human use), with high batch to batch consistency and scalability to meet your exact specifications required.
Due to the high selectivity and efficacy of peptides in drug development, there is an increased interest in peptides in pharmaceutical research and development.
Bio Basic has the capacity to synthesize hundreds of pharmaceutical grade peptides with GMP equivalent standards and high batch to batch consistency to meet your exact specifications required.
To supplement our peptide synthesis service, Bio Basic offers a guaranteed TFA removal service (of < 1% TFA content) for peptides if required.
Trifluoroacetic acid (TFA) is typically used in peptide synthesis during the process of cleaving peptides from their respective resin, as well as an ion pairing agent in HPLC purifications. Therefore synthesized peptides are usually in the form of TFA salts (up to 45% TFA content).
When TFA-salt containing peptides are used in cellular assays, these TFA-salts can be quite problematic as they are known to cause interferences with the resulting experiment, thereby causing significant discrepancies in data.
Bio Basic can offer free solubility testing to make recommendations on dissolving your peptide.
Peptide solubilization can often be quite a tricky problem. For the first attempt to determine the solubility, we recommend dissolving an aliquot into your buffer of choice, by vortexing and sonication if necessary.
It is vitally important that before you order your peptide, determine if it will be soluble in a medium that will be compatible with the experiments you wish to run. After which, we recommend that you first attempt to solubilize a small portion of the peptide. This ensures that NOT all peptide is put into an inappropriate solvent.
For all peptides, usually water or diluted PBS solubilizes the peptide, however after final lyophilization and dependent upon your particular requirements, you may find it necessary to take other actions to solubilize your peptide. Normally, many peptides are easily solubilized as long as you keep the primary amino acid sequence in mind, and follow the guidelines below:
Bio Basic has the capacity to synthesize hundreds of GMP equivalent standards and high batch to batch consistency to meet your exact specifications required.
A vast selection of premade peptides are available at Bio Basic which are of the highest quality and most affordable in the industry.
Modification Type | Price |
---|---|
{H-},Free amino group | Free |
{Ac},Acetylation | – |
{Br-Ac},Bromoacetyl | 50.4 |
{Bromopropionyl} | 50.4 |
{Cl-Ac},Chloroacetyl | 50.4 |
{Fmoc},9-Fluorenylmethyloxycarbonyl | Free |
{Z},{CBZ},Benzyloxycarbonyl | – |
{Bz},benzoyl | – |
{4-F-Bz} | 50.4 |
{Cl-Ac},Chloroacetyl | 30 |
{Boc},tertbutoxycarbonyl | 114 |
{Suc},succinyl | 13.2 |
{MeO-Suc} | 30 |
Sebacic acid | 13.2 |
{Allyl},allyl | 114 |
{Acryl},acryl | 114 |
{Alloc},allyloxycarbonyl | 114 |
{For}, Formylation | 30 |
{HPP},4-Hydroxyphenylpropionic acid | 30 |
{pGlu},{Pyr},Pyroglutamyl | 20.4 |
{LA}, Lipoic acid | 30 |
{Mpa},3-Mercaptopropyl | 30 |
{6-mercaptohexanoic acid} | 114 |
{Mal}, Maleimide, Maleoyl-b-Ala | 396 |
Mal-Acp | 396 |
{MTX}, Methotrexate | 114 |
{PEG1900}, PEG1900-NH- | 114 |
{NH2-PEG2000}, NH2-PEG2000-NH-Suc- | 114 |
{mPEG2000}, MeO-PEG2000-NH- | 114 |
{mPEG3000}, MeO-PEG3000-NH- | 114 |
{mPEG5000}, MeO-PEG5000-NH- | 114 |
{SATA}, S-acetylthioacetate | 114 |
{SATP}, S-acetylthiopropionate | 114 |
{Cholesteryl-}, Cholesteryl chloroformate | 114 |
{Glucose-} | 210 |
{Fructose-} | 210 |
Pyridin-1-yl-Acetyl- | 240 |
4-Dimethylamino-Pyridin-1-yl- | 240 |
Adamantanecarbonyl- | 240 |
Phenylacetic acid | 240 |
4-Biphenyl sulfonyl- | 240 |
Nitrilotriacetyl- | 240 |
N-Propargylglycine- | 240 |
HYNIC- | 240 |
Morpholine-4-carbonyl- | 240 |
5-amino-2-nitrobenzonic acid | 240 |
Azido-PEG4- | inquire |
GAC- | inquire |
{Aoa} | inquire |
N3-Gly | inquire |
N3-Acp | inquire |
Modification Type | Price |
---|---|
{But}, Butyric acid C4 | 50.4 |
{Iba}, isobutyric acid C4 | 159.6 |
{Hex}, Hexanoic acid C6 | 50.4 |
{Oct}, Octanoic acid C8 | 50.4 |
{F-Oct}, Perfluoro Octanoic acid F15C8 | 159.6 |
{Dec}, Decanoic acid C10 | 50.4 |
{F-Dec}, Perfluoro Decanoic acid F19C10 | 159.6 |
{Lau}, Lauric acid C12 | 50.4 |
{F-Lau}, Perfluoro Lauric acid F23C12 | 159.6 |
{Myr}, Myristic acid C14 | 50.4 |
{F-Myr}, Perfluoro Myristic acid F27C14 | 159.6 |
{Pal}, Palmitic acid C16 | 50.4 |
{Ste}, Stearic acid C18 | 50.4 |
{Ste}, Stearic acid C18 | 50.4 |
Oleic Acid- | 159.6 |
{Pam3C}, Tripalmitoyl cysteine, {Pal-Cys(Pal)2-} | 319.2 |
Modification Type | Price |
---|---|
{-OH}, free acid group | – |
{NH2}, Amidation | – |
{-CHO}, peptide aldehydes | 459.6 |
{-ol}, alcohol peptide | 210 |
{CMK}, chloromethylketone | 459.6 |
{FMK}, Fluoromethylketone | 459.6 |
{Cya}, Cysteamide | 210 |
{pNA},p-nitroaniline | 159.6 |
{-ONP}, para-nitrophenol | 210 |
{AMC},7-Amino-4-methylcoumarin | 210 |
{AFC} | 270 |
-OMe (C-terminal) | $99.60 |
-OEt (C-terminal) | $99.60 |
-OBzl (C-terminal) | $99.60 |
-OtBu (C-terminal) | $210.00 |
{-OSu}, hydroxysucinimide ester | 459.6 |
-NHMe (C-terminal) | $159.60 |
-NHEt (C-terminal) | $159.60 |
-NHisopen (C-terminal) | $240.00 |
-NH(CH2)6 (C-terminal) | $240.00 |
-NHPh (C-terminal) | $159.60 |
{NHEt(O)EtNH-Fmoc}, 2,2′-Oxydi Ethanamine-Fmoc | 210 |
{NHEt(EtNH-Myr)2} | 240 |
-NH(OMe)Me (C-terminal) | $240.00 |
-TBzl (C-terminal) | $210.00 |
-NHNH2 (C-terminal) | $159.60 |
-ED (C-terminal), -NH-CH2CH2-NH2 | $159.60 |
-BD (C-terminal), -NH-CH2CH2CH2CH2-NH2 | $159.60 |
-Pyrenemethylamine | Inquire |
chloro-4-hydroxyanilide | Inquire |
4-amino-2-Chlorophenol | Inquire |
-octyl ester | Inquire |
-ED-Fmoc | Inquire |
Modification Type | Price |
---|---|
{D-Ala} | 20.4 |
{D-Arg} | 50.4 |
{D-Asp} | 30 |
{D-Asn} | 30 |
{D-Cys} | 30 |
{D-Glu} | 30 |
{D-Gln} | 36 |
{D-His} | 30 |
{D-Allo-Ile} | 36 |
{D-Leu} | 20.4 |
{D-Lys} | 30 |
{D-Met} | 20.4 |
{D-Pro} | 20.4 |
{D-Phe} | 20.4 |
{D-Ser} | 30 |
{D-Tyr} | 30 |
{D-Thr} | 30 |
{D-Trp} | 50.4 |
{D-Val} | 20.4 |
Modification Type | Price |
---|---|
{Beta-Asp} | 30 |
{D-Beta-Asp} | 36 |
{Gamma-Glu} | 30 |
{D-Gamma-Glu} | 36 |
{Cys(Cam)} | 120 |
{Cys(Acm)} | 30 |
{Cys(tBu)} | 30 |
{Met(O)} | 36 |
{D-Met(O)} | 48 |
{Met(O)2} | 36 |
{D-Met(O)2} | 48 |
{Lys(Ac)} | 30 |
{Ac-Lys} | 36 |
{Lys(Dde)} | 144 |
{Tle} | 36 |
{Ser(octanoic acid)} | 222 |
{D-Ser(octanoic acid)} | 222 |
{Aib} | 30 |
{Abu} | 30 |
{D-Abu} | 30 |
{Hyp} | 20.4 |
{Phg} | 20.4 |
{D-Phg} | 20.4 |
{Nva} | 30 |
{D-Nva} | 30 |
{Nle} | 30 |
{D-Nle} | 30 |
{Cit} | 30 |
{D-Cit} | 36 |
{Orn} | 30 |
{D-Orn} | 36 |
{Pen} | 60 |
{D-Pen} | 30 |
{Cpg}, cyclopentylglycine | 36 |
{Cha} | 30 |
{D-Cha} | 30 |
{Chg} | 30 |
{D-Chg} | 30 |
{Dab} | 60 |
{Dap} | 60 |
{Pra} | 36 |
{D-Pra} | 36 |
{Gly(allyl)} | 36 |
{D-Gly(allyl)} | 36 |
{D-1-Nal} | 30 |
{L-1-Nal} | 30 |
{D-2-Nal} | 30 |
{L-2-Nal} | 30 |
{D-2-Pal} | 30 |
{L-2-Pal} | 30 |
{D-3-Pal} | 30 |
{L-3-Pal} | 30 |
{D-4-Pal} | 30 |
{L-4-Pal} | 30 |
{Cys(pMeBzl)} | 30 |
{Cys(pMeOBzl)} | 30 |
{Oic} | 36 |
{Tic} | 36 |
{Cys(Bzl)} | 30 |
{Epsilon-Lys} | 30 |
{D-Epsilon-Lys} | 36 |
{5-ASA} | 114 |
{Bpa} | 114 |
{Pip} | 36 |
{Nip} | 48 |
{2-Aze} | 48 |
{3-Aze} | 60 |
[Psi(CH2NH)] | 780 |
[CS-NH] | 780 |
{Se-Met} | Inquire |
{Se-Cys} | Inquire |
{DOPA} | Inquire |
{isoGln} | 60 |
{D-isoGln} | 96 |
Cys(Mal-PEG2000) | 390 |
{Ser(O-b-D-Glc)} | 780 |
{Thr(O-b-D-Glc)} | 780 |
{Tyr(O-b-D-Glc)} | 780 |
{Rink Linker} | Inquire |
{Thr(OAc)} | Inquire |
{Delta-Orn} | Inquire |
{5,5-Dime-Pro} | Inquire |
{Gla} | Inquire |
{Kep} | Inquire |
{X}, 20 Kinds mixture amino acids | 30 |
{X-deCys} | 30 |
{G/A/S/V/L/D/K/M/F/Y} | 30 |
{A/P/T/N/Q/E/H/R/W} | 30 |
{K(75)X(25)} | 30 |
{R(25)K(25)X(50)} | 30 |
{E(25)D(25)X(50)} | 30 |
{K(25)Q(25)X(50)} | 30 |
{E(25)T(25)X(50)} | 30 |
Modification Type | Price |
---|---|
Biotin (N-Terminal) | 30 |
EDBiotin (C terminus) | 240 |
Lys(Biotin) (middle) | 192 |
Lys(Biotin) (C temrinus) | 192 |
Lys(Biotin) (N terminus) | 96 |
Biotin-LC (N-Terminal) | 30 |
Lys(LC-Biotin) (middle) | 230.4 |
Lys(LC-Biotin) (C terminus) | 230.4 |
Orn(Bio) | 230.4 |
-NH-PEG3-Bio | 230.4 |
FITC (N-Terminal) | 114 |
EDFITC (C temrinus) | 288 |
Lys(FITC) (middle) | 240 |
Lys(FITC) (C temrinus) | 240 |
Lys(FITC) (N terminus) | 120 |
FITC-LC (N-Terminal) | 114 |
5-FAM (N-Terminal) | 114 |
ED5-FAM (C temrinus) | 288 |
Lys(5-FAM) (middle) | 240 |
Lys(5,6-FAM) | 240 |
Lys(5-FAM) (C temrinus) | 240 |
Lys(5-FAM) (N-Terminus) | 120 |
5-FAM-LC (N-Terminal) | 114 |
Dansyl (N-Terminal) | 114 |
EDDansyl (C temrinus) | 288 |
Lys(Dansyl) (middle) | 240 |
Lys(Dansyl) (C temrinus) | 240 |
Lys(Dansyl) (N-Terminus) | 120 |
Dansyl-LC (N-Terminal) | 114 |
TAMRA (N-Terminal) | 228 |
5(6)-TAMTA- | 228 |
EDTAMRA (C temrinus) | 468 |
Lys(TAMRA) (middle) | 390 |
Lys(TAMRA) (C temrinus) | 390 |
Lys(TAMRA) (N-terminus) | 198 |
TAMRA-LC (N-Terminal) | 228 |
Lys(Dnp) (middle) | 96 |
D-Lys(Dnp) (middle) | 192 |
Dab(Dnp) (middle) | 192 |
Dap(Dnp) (middle) | 192 |
EDDnp (C terminus) | 288 |
MCA (N-Terminal) | 114 |
Lys(MCA) (middle) | 390 |
Lys(MCA) (C temrinus) | 390 |
Lys(MCA) (N-terminus) | 198 |
3-Indolylacetic acid (N-Terminal) | 30 |
Cys(Npys) (N-terminus) | 96 |
PyBA- (N-Terminal), 1-pyrenebutyric acid | 114 |
Lys(PyBA) | 198 |
Fa- (N-Terminal), 3-[2-2furyl]acrylic | 114 |
acid | |
Rhodamine B- (N-Terminal) | 114 |
D-Luciferin (N-terminus) | 420 |
Cy3- (N-Terminal) | Inquire |
NBD | Inquire |
Modification Type | Price |
---|---|
{D-2-Cl-Phe} | 36 |
{L-2-Cl-Phe} | 36 |
{D-3-Cl-Phe} | 36 |
{L-3-Cl-Phe} | 36 |
{D-4-Cl-Phe} | 30 |
{L-4-Cl-Phe} | 30 |
{D-3,4-DiCl-Phe} | 48 |
{L-3,4-DiCl-Phe} | 48 |
{D-4-Br-Phe} | 30 |
{L-4-Br-Phe} | 30 |
{D-3-F-Phe} | 36 |
{L-3-F-Phe} | 36 |
{D-4-F-Phe} | 30 |
{L-4-F-Phe} | 30 |
{D-4-NO2-Phe} | 30 |
{L-4-NO2-Phe} | 30 |
{D-4-I-Phe} | 30 |
{L-4-I-Phe} | 30 |
{D-3-CN-Phe} | 36 |
{L-3-CN-Phe} | 36 |
{D-4-CN-Phe} | 30 |
{L-4-CN-Phe} | 30 |
{D-2-Me-Phe} | 36 |
{L-2-Me-Phe} | 36 |
{D-4-Me-Phe} | 30 |
{L-4-Me-Phe} | 30 |
{D-4-NH2-Phe} | 48 |
{L-4-NH2-Phe} | 48 |
{D-3-Cl-Tyr} | 48 |
{L-3-Cl-Tyr} | 30 |
{D-3,5-DiCl-Tyr} | 48 |
{L-3,5-DiCl-Tyr} | 48 |
{D-3,5-DiBr-Tyr} | 48 |
{L-3,5-DiBr-Tyr} | 48 |
{D-3-I-Tyr} | 48 |
{L-3-I-Tyr} | 48 |
{D-3,5-DiI-Tyr} | 48 |
{L-3,5-DiI-Tyr} | 48 |
{D-3-NO2-Tyr} | 48 |
{L-3-NO2-Tyr} | 30 |
{D-3,5-DiNO2-Tyr} | 48 |
{L-3,5-DiNO2-Tyr} | 48 |
{L-3-F-Tyr} | 48 |
Modification Type | Price |
---|---|
{Har}, HomoArg | 36 |
{Hcy}, HomoCys | 30 |
{HPh}, HomoPhe | 36 |
{D-HPh}, D-HomoPhe | 36 |
{Hse}, HomoSer | 30 |
{D-Hse}, D-HomoSer | 36 |
{HomoCit}, HomoCit | 36 |
{D-HomoCit}, D-HomoCit | 36 |
{HomoLeu}, HomoLeu | 36 |
{HomoPro}, HomoPro | 36 |
{D-HomoPro}, D-HomoPro | 36 |
{beta-HomoIle}, beta-HomoIle | 60 |
{beta-HomoLeu}, beta-HomoLeu | 60 |
{beta-HomoMet}, beta-HomoMet | 60 |
{beta-HomoPro}, beta-HomoPro | 60 |
{beta-HomoVal}, beta-HomoVal | 60 |
{beta-HomoAsp}, beta-HomoAsp | 120 |
{beta-HomoAsn}, beta-HomoAsn | 120 |
{beta-HomoGlu}, beta-HomoGlu | 120 |
{beta-HomoGln}, beta-HomoGln | 120 |
{beta-HomoSer}, beta-HomoSer | 120 |
{beta-HomoThr}, beta-HomoThr | 120 |
{beta-HomoTrp}, beta-HomoTrp | 120 |
{beta-HomoTyr}, beta-HomoTyr | 120 |
{Azidohomoalanine}, Azidohomoalanine | 120 |
{beta-HomoAla}, beta-HomoAla | 120 |
{beta-HomoPhe}, beta-HomoPhe | 120 |
{beta-HomoLys}, beta-HomoLys | 120 |
Modification Type | Price |
---|---|
Abz | 30 |
Tyr (3-NO2) | 30 |
Glu(EDANS)-NH2 | 186 |
DABCYL | 168 |
Lys(DABCYL) | 336 |
Lys(Abz) | 336 |
Modification Type | Price |
---|---|
Symmetric 2 Branches (Pure) | 159.6 |
Orn Symmetric 2 Branches (Pure) | 191.52 |
Symmetric 4 Branches (Crude) | 159.6 |
Orn Symmetric 4 Branches (Crude) | 191.52 |
Symmetric 8 Branches (Crude) | 159.6 |
Orn Symmetric 8 Branches (Crude) | 191.52 |
Glu 2 Branches (N temrinus) | 240 |
Glycerol 3 branches (C terminus) | 240 |
Lys(Ala) | 240 |
Lys(Arg) | 240 |
Lys(Asp) | 240 |
Lys(Cys) | 240 |
Lys(Glu) | 240 |
Lys(Leu) | 240 |
Lys(Met)- | 240 |
Lys(Phe)- | 240 |
Lys(Val) | 240 |
Lys(Beta-Asp) | 240 |
Lys(Gama-Glu) | 240 |
Lys(Cholesteryl) | 240 |
Lys(LA) | 240 |
Lys(MTX) | 240 |
Lys(Maleimide) | 360 |
Lys(Mpa) | 240 |
Lys(Pra) | 240 |
Lys(Suc) | 240 |
Lys(pGlu) | 240 |
Lys(For) | 240 |
Lys(Ma) | 240 |
Lys(Pal) | 240 |
Lys(Gama-Glu-Pal) | 444 |
Lys(4-HBA) | 240 |
Lys(Acrylic) | 240 |
Lys(Alkine) | 240 |
{Lys(Alloc)} | 96 |
{Lys(Butanoyl)} | 96 |
Lys(cyclopropanecarboxyl) | 240 |
Lys(Crotonyl) | 240 |
{Lys(3,5-diiodo-4-hydroxybenzoyl)} | 240 |
Lys(HMP) | 240 |
{Lys(Ahx-Diazirine)} | 240 |
{Lys(propargyl)} | 96 |
{Lys(propionyl)} | 96 |
Lys(2-hydroxyisobutyryl) | 240 |
Lys(methylmalony) | 240 |
Lys(HYNIC) | 240 |
BSA-Peptide Cys | 161.29 |
KLH-Peptide Cys | 161.29 |
OVA-Peptide Cys | 161.29 |
Modification Type | Price |
---|---|
{Gly}, 2 atoms | 0 |
{Beta-Ala}, 3 atoms | 0 |
{GABA}, 4 atoms | 0 |
{Ava}, 5 atoms | 36 |
{Ahx}, 6 atoms | 0 |
{8-Aoc} | 72 |
{AEA},aminoethoxyacetic acid | 180 |
{Mini-PEG}, AEEA 9 atoms | 36 |
{Mini-PEG2}, AEEEP 13 atoms | 54 |
{Mini-PEG3},AEEEEP 16 atoms | 72 |
{PEG4} | 180 |
{PEG6} | 180 |
{PEG8} | 180 |
{PEG11} | 180 |
{PEG-12} | 180 |
{Ado} | 180 |
{ANP Linker} | 180 |
Modification Type | Price |
---|---|
{Arg(Me)} | 288 |
{ADMA},{Arg(Me)2} asymmetrical | 288 |
{SDMA},{Arg(Me)2} symmetrical | 384 |
{Tyr(Me)} | 36 |
{Thr(Me)} | 36 |
{Ser(Me)} | 36 |
{Cys(Me)}, SMC | 30 |
{Lys(Me)} | 192 |
{Lys(Me2)} | 96 |
{Lys(Me3)} | 192 |
{L-2-Me-Trp} | 228 |
{D-2-Me-Trp} | 228 |
{Tyr(Et)} | 96 |
{D-Tyr(Et)} | 96 |
{Orn(Me)3} | 288 |
{L-1-Me-Trp} | 384 |
Modification Type | Price |
---|---|
{N-Me-Ala} | 156 |
{N-Me-Phe} | 156 |
{N-Me-Leu} | 156 |
{N-Me-Ile} | 156 |
{N-Me-Val} | 156 |
{N-Me-Met} | 156 |
{N-Me-Nle} | 156 |
{N-Me-Nva} | 156 |
{N-Me-Gly}, Sar | 20.4 |
{N-Me-Ser} | 312 |
{N-Me-Tyr} | 312 |
{N-Me-Thr} | 312 |
{N-Me-Asp} | 312 |
{N-Me-Glu} | 312 |
Modification Type | Price |
---|---|
Mono Disulfide bridge | 160 |
Double Disulfide bridge | 530.4 |
Triple Disulfide bridge | Inquire |
Random Triple Disulfide bridge | 319.2 |
Same Seq. Inter-Disulfide bridge | 159.6 |
Different Inter-Disulfide bridge | 320.4 |
Amide cyclic (end) | 560.4 |
Amide cyclic (Side chain) | 639.6 |
Orn side chain Amide cyclic | 639.6 |
Thioester cyclic | 530.4 |
Lactone cyclic | 530.4 |
Modification Type | Price |
---|---|
{pSer} | 96 |
{pTyr} | 96 |
{pThr} | 96 |
{D-pSer} | 288 |
{D-pTyr} | 288 |
{D-pThr} | 288 |
Di-sites in sequence | 288 |
Tri-sites in sequence | 576 |
4-sites in sequence | 864 |
5-sites in sequence | 1152 |
Synthesis Scale | 25 nmole | 100 nmole | 200 nmole | 400 nmole | >400 nmole | |
---|---|---|---|---|---|---|
Price / Base | $0.45 | $0.60 | $1.00 | $1.50 | Inquire | |
Purification Price | HA | free | free | free | free | |
PAGE | X | $10.00 | $15.00 | $20.00 | Inquire | |
HPLC | X | $20.00 | $25.00 | $30.00 | Inquire | |
Guaranteed Yield# (OD) | HA | 2 ODs | 5 ODs | 10 ODs | 20 ODs | Inquire |
PAGE | X | 2 ODs | 5 ODs | 10 ODs | Inquire | |
HPLC | X | 2 ODs | 5 ODs | 10 ODs | Inquire | |
Available Length (Base) | HA | 11-59 base | 11-59 base | 11-59 base | 11-59 base | Inquire |
PAGE | X | 11-59 base | 11-99 base | 11-130 base | Inquire | |
HPLC | X | 11-59 base | 11-99 base | 11-130 base | Inquire |
5’AMCA (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
AMCA5-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $150.00 |
AMCA5-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $200.00 |
AMCA5-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $300.00 |
AMCA5-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $600.00 |
3’AMCA (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
AMCA3-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $150.00 |
AMCA3-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $200.00 |
AMCA3-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $130.00 |
AMCA3-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $260.00 |
5′ 6-FAM-3’TAMRA NHS Ester (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
FT-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $180.00 |
FT-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $260.00 |
FT-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $380.00 |
FT-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $760.00 |
5′ 6-FAM-3’BHQ-1 (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
FB-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $180.00 |
FB-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $260.00 |
FB-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $380.00 |
FB-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $760.00 |
Synthesis Scale | 25 nmole | 100 nmole | 200 nmole | 400 nmole | >400 nmole | |
---|---|---|---|---|---|---|
Price / Base | $0.45 | $0.60 | $1.00 | $1.50 | Inquire | |
Purification Price | HA | free | free | free | free | |
PAGE | X | $10.00 | $15.00 | $20.00 | Inquire | |
HPLC | X | $20.00 | $25.00 | $30.00 | Inquire | |
Guaranteed Yield# (OD) | HA | 2 ODs | 5 ODs | 10 ODs | 20 ODs | Inquire |
PAGE | X | 2 ODs | 5 ODs | 10 ODs | Inquire | |
HPLC | X | 2 ODs | 5 ODs | 10 ODs | Inquire | |
Available Length (Base) | HA | 11-59 base | 11-59 base | 11-59 base | 11-59 base | Inquire |
PAGE | X | 11-59 base | 11-99 base | 11-130 base | Inquire | |
HPLC | X | 11-59 base | 11-99 base | 11-130 base | Inquire |
5’AMCA (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
AMCA5-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $150.00 |
AMCA5-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $200.00 |
AMCA5-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $300.00 |
AMCA5-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $600.00 |
3’AMCA (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
AMCA3-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $150.00 |
AMCA3-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $200.00 |
AMCA3-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $130.00 |
AMCA3-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $260.00 |
5′ 6-FAM-3’TAMRA NHS Ester (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
FT-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $180.00 |
FT-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $260.00 |
FT-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $380.00 |
FT-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $760.00 |
5′ 6-FAM-3’BHQ-1 (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
FB-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $180.00 |
FB-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $260.00 |
FB-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $380.00 |
FB-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $760.00 |
Synthesis Scale | 25 nmole | 100 nmole | 200 nmole | 400 nmole | >400 nmole | |
---|---|---|---|---|---|---|
Price / Base | $0.45 | $0.60 | $1.00 | $1.50 | Inquire | |
Purification Price | HA | free | free | free | free | |
PAGE | X | $10.00 | $15.00 | $20.00 | Inquire | |
HPLC | X | $20.00 | $25.00 | $30.00 | Inquire | |
Guaranteed Yield# (OD) | HA | 2 ODs | 5 ODs | 10 ODs | 20 ODs | Inquire |
PAGE | X | 2 ODs | 5 ODs | 10 ODs | Inquire | |
HPLC | X | 2 ODs | 5 ODs | 10 ODs | Inquire | |
Available Length (Base) | HA | 11-59 base | 11-59 base | 11-59 base | 11-59 base | Inquire |
PAGE | X | 11-59 base | 11-99 base | 11-130 base | Inquire | |
HPLC | X | 11-59 base | 11-99 base | 11-130 base | Inquire |
5’AMCA (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
AMCA5-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $150.00 |
AMCA5-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $200.00 |
AMCA5-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $300.00 |
AMCA5-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $600.00 |
3’AMCA (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
AMCA3-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $150.00 |
AMCA3-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $200.00 |
AMCA3-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $130.00 |
AMCA3-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $260.00 |
5′ 6-FAM-3’TAMRA NHS Ester (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
FT-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $180.00 |
FT-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $260.00 |
FT-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $380.00 |
FT-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $760.00 |
5′ 6-FAM-3’BHQ-1 (mass QC) | Synthesis Scale | Purification Method | Yield | Price/Base ($) | Mod.& Pur. Cost ($) |
---|---|---|---|---|---|
FB-100 | 100 nmole | HPLC | 2 ODs | $0.60 | $180.00 |
FB-200 | 200 nmole | HPLC | 5 ODs | $1.00 | $260.00 |
FB-400 | 400 nmole | HPLC | 10 ODs | $1.50 | $380.00 |
FB-1000 | 1 µmole | HPLC | 20 ODs | $3.00 | $760.00 |
HAP stands for “High Affinity Purification”; it is a patented, novel purification method for custom oligos developed by Bio Basic. After synthesis the DMT-ON-oligo in the crude oligo mixture is selectively absorbed on a high affinity resin within a HAP column, this allows incomplete oligo fragments pass through while keeping majority of the full length oligos. The full length oligo is retrieved by removing the DMT protection group under mild acid conditions.
The HAP process provides two major advantages, higher purity, superior to that of the De-Salted method (purity of a standard 20 bases-HAP is >85%, 30 bases-HAP > 80% etc.), and lower cost compared to PAGE or HPLC methods.
HAP stands for “High Affinity Purification”; it is a patented, novel purification method for custom oligos developed by Bio Basic. After synthesis the DMT-ON-oligo in the crude oligo mixture is selectively absorbed on a high affinity resin within a HAP column, this allows incomplete oligo fragments pass through while keeping majority of the full length oligos. The full length oligo is retrieved by removing the DMT protection group under mild acid conditions.
The HAP process provides two major advantages, higher purity, superior to that of the De-Salted method (purity of a standard 20 bases-HAP is >85%, 30 bases-HAP > 80% etc.), and lower cost compared to PAGE or HPLC methods.
HAP stands for “High Affinity Purification”; it is a patented, novel purification method for custom oligos developed by Bio Basic. After synthesis the DMT-ON-oligo in the crude oligo mixture is selectively absorbed on a high affinity resin within a HAP column, this allows incomplete oligo fragments pass through while keeping majority of the full length oligos. The full length oligo is retrieved by removing the DMT protection group under mild acid conditions.
The HAP process provides two major advantages, higher purity, superior to that of the De-Salted method (purity of a standard 20 bases-HAP is >85%, 30 bases-HAP > 80% etc.), and lower cost compared to PAGE or HPLC methods.
Copyright © 2023 MarLiJu. All Rights Reserved